Observational studyMedicine2025
Association of an antioxidant-rich diet with all-cause and cardiovascular mortality in hypertensive patients: A prospective study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of prognostic nutritional index with all-cause and CVD mortality in hypertensive individuals.Scientific reports · 2026Article
- Resveratrol attenuates pyroptosis and neuroinflammation by inhibiting the TLR4/NF-κB/AIM2 pathway in ischemic stroke rats.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study investigates the relationship between the composite dietary antioxidant index (CDAI) and the risk of all-cause and cardiovascular mortality in individuals with hypertension, aiming to provide dietary recommendations to reduce mortality. Data were sourced from the National Health and Nutrition Examination Survey (NHANES) database. The best cut-off for CDAI in relation to survival outcomes was determined using the maximally selected rank statistics method. Multivariate Cox regression analysis was used to examine the association between CDAI and mortality risks, and hazard ratios with 95% confidence intervals were calculated. Restricted cubic spline (RCS) curves were used to visualize the correlations. After analyzing data from 22,591 hypertensive adults, the optimal CDAI cut-off was found to be -1.23, categorizing participants into high and low CDAI groups. The results showed that the high CDAI group had a lower risk of cardiovascular and all-cause mortality (HR [95% CI]: 0.73 [0.61-0.87] and 0.79 [0.71-0.88], respectively). RCS analysis indicated a negative linear relationship with cardiovascular mortality and a nonlinear relationship with all-cause mortality. Subgroup and sensitivity analyses confirmed these findings. In conclusion, CDAI is a valuable predictor of long-term mortality risks in hypertensive individuals and can serve as a cost-effective tool for assessing their prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.